Safety of a nutritional formula for muscle maintenance with semaglutide
Part of Hormones & metabolism clinical trials.
This study tests a nutritional formula designed to help maintain muscle while you are on a calorie-restricted diet and taking the weight-loss medication semaglutide. It is looking at whether the formula is safe and well-tolerated in adults with a BMI between 25 and 34.9 who have already reached a weekly semaglutide dose of 1 mg.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently taking semaglutide (e.g., Ozempic or Wegovy) for weight loss and have reached a weekly dose of 1 mg.
- Your BMI is between 25.0 and 34.9.
- You do not have any serious or unstable medical conditions (like heart, liver, or kidney problems).
- You are not allergic to any ingredients in the study nutritional formula.
- You are not taking diabetes medications or certain supplements other than fish oil, multivitamin, magnesium, vitamin D, or vitamin C.
- You have not used narcotics, blood thinners, corticosteroids, or recreational drugs in the last 30 days, and you drink no more than one alcoholic beverage per day.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding a natural compound called 20E (20-hydroxyecdysone) to the weight-loss drug semaglutide can help people with obesity lose more weight and keep muscle. You would take both medications and follow a diet and exercise plan.
This study tests whether gradually lowering the dose of the weight-loss drug semaglutide can help people who have already lost weight keep it off. You may join if you are already taking weekly semaglutide and have lost at least 10% of your starting weight or are at a healthy weight after losing 5%.
This study tests a small implant placed under the skin that slowly releases semaglutide, a medication that helps with weight management. It's for people who are overweight but do not have diabetes.
This study tracks how semaglutide (an injectable medication that reduces appetite) helps adults lose weight in everyday life. Researchers want to understand how well it works and how safe it is for people starting the treatment.
This study tests if a medication called semaglutide can help people with obesity lose weight by changing the bacteria in their gut. You may be able to join if you have obesity, have tried to lose weight before, and are generally healthy.
This study tests whether taking HMB and vitamin D can help older adults with type 2 diabetes keep their muscle mass while they start taking semaglutide for weight loss. It may help prevent muscle loss during weight management.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.